Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cerni

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Der Anaesthesist|January 1, 1983
[Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation]R Khosropour, C Cerni, F Lackner, et al.
Journal of Cellular Biochemistry|July 1, 1996
ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modifiedJ Wesierska-Gadek, A Bugajska-Schretter, C Cerni
Molecular Biology Reports|December 24, 1997
Expression of mouse RNase MRP RNA in human embryonic kidney 293 cellsW Rossmanith, E Bettinger, C Cerni, et al.
Osterreichische Zeitschrift Fur Onkologie. Austrian Journal of Oncology|January 1, 1975
[Halo Nevus (Morbus Sutton): model of an immunological tumor regression]M Micksche, C Cerni, W Gebhart, et al.
Virology|March 1, 1991
Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7G Meneguzzi, C Cerni, M P Kieny, et al.
Voprosy Onkologii|January 1, 1977
[Basic problems of immunotherapy]H Wrba, C Cerni, P Fisher, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
Biological effects of high level c-myc expression in FR3T3 fibroblastsM Zerlin, M A Julius, C Cerni, et al.
Oncogene|November 1, 1990
Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformationB Binétruy, J Schiller, D Lowy, et al.
Research in Virology|September 1, 1996
Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigensM Bagot, D Charue, C Cerni, et al.
Experientia|January 1, 1981
Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitroR Lenzhofer, C Cerni, I Fröhlich, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Der Anaesthesist|January 1, 1983
[Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation]R Khosropour, C Cerni, F Lackner, et al.
Journal of Cellular Biochemistry|July 1, 1996
ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modifiedJ Wesierska-Gadek, A Bugajska-Schretter, C Cerni
Molecular Biology Reports|December 24, 1997
Expression of mouse RNase MRP RNA in human embryonic kidney 293 cellsW Rossmanith, E Bettinger, C Cerni, et al.
Osterreichische Zeitschrift Fur Onkologie. Austrian Journal of Oncology|January 1, 1975
[Halo Nevus (Morbus Sutton): model of an immunological tumor regression]M Micksche, C Cerni, W Gebhart, et al.
Virology|March 1, 1991
Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7G Meneguzzi, C Cerni, M P Kieny, et al.
Voprosy Onkologii|January 1, 1977
[Basic problems of immunotherapy]H Wrba, C Cerni, P Fisher, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
Biological effects of high level c-myc expression in FR3T3 fibroblastsM Zerlin, M A Julius, C Cerni, et al.
Oncogene|November 1, 1990
Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformationB Binétruy, J Schiller, D Lowy, et al.
Research in Virology|September 1, 1996
Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigensM Bagot, D Charue, C Cerni, et al.
Experientia|January 1, 1981
Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitroR Lenzhofer, C Cerni, I Fröhlich, et al.
Pageof 6